The Association for Value-Based Cancer Care (AVBCC) will once again be meeting in person at the New York Athletic Club. The live event will be invitation-only, limiting the number of guests to follow safety guidelines. There will be a virtual simulcast of the entire Summit for those who cannot join us in New York.

The One Conference That Covers It All

Join us for this exclusive invitational forum that provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem. Nearly 100% of attendees agreed the content, topics, sessions, and information were relevant and up-to-date.

Top Reasons to Participate in the 2022 Summit

• LEARN to stay competitive in the ever-changing field of oncology.
• EXPLORE cutting-edge methodologies you can implement in your company or institution immediately.
• ACCESS timely and accurate information from sources you can rely on.
• GAIN insights from a diverse range of practitioners, pharmacists, payers, policymakers, and other key stakeholders.
• NETWORK with nationally recognized thought leaders.

Registration

Please Note:
The live event is available on a first come, first served basis due to limited capacity. Sponsors will be guaranteed the opportunity to attend live. The general public is encouraged to request an invite to join and will be notified when accepted.

In alignment with the New York Athletic Club, live attendees will be required to be vaccinated against the COVID-19 virus. If you are traveling to the conference from out of state, please be prepared to show proof of vaccination. For questions and concerns, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

The AVBCC Summit continues to empower all oncology care professionals to maximize value in cancer care by focusing on clinical, cost, and access issues. Secure your seat at the table today!

Take a look at the exciting lineup for the 2022 Summit! Sessions feature experts and respected faculty from across the field. This is a must-attend event for all stakeholders in the cancer-care value equation. Secure your spot today!

• Wednesday, October 19
• Thursday, October 20
• Friday, October 21

• Wednesday, October 19
  7:45am - 8:00am	Orchestrating Optimal Change Through Value-Based Agreements - Welcome
  8:00am - 8:30am	Value-Based Agreements: State of the Market Report
  8:30am - 9:15am	Headwinds and Tailwinds Ahead for Value-Based Agreements
  9:15am - 10:00am	Transitioning from Volume-Based Discounts to Value-Based Agreements
  10:00am - 10:45am	The Practical Framework for Value-Based Agreements
  10:45am - 11:30am	Gene Therapy Value-Based Purchasing and the Impact of Medicaid Best Price Changes
  11:30am - 12:15pm	Value-Based Agreement Models Pharma Value-Based Programs: What Worked, Failed and Is the Future
  12:15pm - 1:30pm	Lunch Keynote
  1:30pm - 2:30pm	Data and the Future Requirements to Operationalize and Support Value-Based Agreements Legal and Regulatory Issues
  2:30pm - 3:30pm	CMS: The Regulator Point of View Creating Collaborative Partnerships: Stakeholder Perspectives
  3:30pm - 4:15pm	The Value-Based Agreement Roadmap from Strategy to Design Through Implementation Understanding the Economics of the Oncology Drug Pricing Ecosystem
  4:15pm - 5:00pm	Summarizing Business Case for Pharma Participation in Triangulated Value-Based Agreements

• Thursday, October 20
  7:00am - 7:15am	Opening Comments
  7:15am - 8:15am	Near-Term Oncology Drug Trend and Pipeline Review
  8:15am - 9:00am	Economic Trends and Forecast in Cancer Care
  9:00am - 9:45am	Bundled Payments in Cancer Care: Surgery and Beyond
  9:00am - 9:40am	Washington Legislation and Policy Impacts
  9:45am - 10:00am	Integra Connect Results Report on OCM
  10:00am - 11:00am	Lessons Learned from OCM That Should Be Incorporated into EOM and Future Cancer Care Models
  10:45am - 11:40am	Selling the Cell – Cost-Benefit Considerations for Complex Therapeutics
  11:00am - 11:45am	Community Cancer Care and Its Future Path Ahead Telehealth/Digital Health Tools in Cancer Care
  11:45am - 12:30pm	What Is the Role of Centers of Excellence? Employers
  11:45am - 12:40pm	Employers’ Positions on Cancer Care
  12:30pm - 1:00pm	Lunch Panel
  1:00pm - 1:15pm	Off Broadway: We Must Do Better
  1:15pm - 1:45pm	Supporting Patients: We Must Do Better
  1:45pm - 2:30pm	Payers’ Initiatives: Future Impact on Cancer Care 340B Program: Current State and Outcomes
  2:30pm - 3:15pm	Addressing the Current PBM Models and Impact on Value-Based Care 340B Programs: A Look at Solutions
  3:15pm - 4:00pm	Pharmaceutical Industry Role in Value-Based Agreements Precision Medicine’s Role and Impact on Value-Based Agreements
  4:00pm - 4:45pm	Future Models of Precision Medicine Disparities and the Impact on Cancer Care
  4:45pm - 5:30pm	Unified Leadership Efforts to Address and Shape the Future of Cancer Care
  5:30pm - 6:15pm	Cancer Research and the Road Ahead
  6:15pm - 9:00pm	Swim Across America Reception

• Friday, October 21
  7:00am - 8:00am	Radiation Oncology: Under Clinical Pathways, Transparency, and with Risk Share The Business Path: From Innovation to Market Access FTC Launces Investigation into PBMs TBD
  8:00am - 9:00am	Wall Street and Capital Markets and the Impact on Cancer Care Drug Pricing and Transformation Realities and Implications on the Road Ahead Leadership for Navigation: How Leadership Promotes Values of Navigation for Sustainability New Site of Cancer Care Models
  9:00am - 10:00am	Biosimilars Oncology Drug Benefit Designs and Pricing Realities Now and Tomorrow Out of Pocket Out of Time: Evolving to Address Financial Toxicity and Designing for the Future Why Wall Street Is Interested in Investing in Cancer Care
  10:00am - 11:00am	New Patient-Centric Cancer Care Models Oncology Drug Supply Channels and the Move to Smart Networks and Supporting Value-Based Agreements Wall Street and Capital Markets and the Influence on Cancer Care Revenue Cycle Management System and Ability to Manage Value-Based Agreements
  11:00am - 12:00pm	Telehealth/Digital Health and Integration into Care Management Medically Integrated Pharmacy and Future Models of Integration Practice Transformation Through Value-Based Analytics Technology Transfer for Cell Therapy and Gene Therapy: Will These Advances Be Provided by Community Hospital Cancer Programs?
  12:00pm - 12:30pm	Lunch
  12:30pm - 1:15pm	Fireside Chat with Scott Gottlieb
  1:15pm - 2:00pm	Industry Perspectives on Cancer Care The Evolving Role of Social Determinants of Health in Value-Based Care Goals
  2:00pm - 3:00pm	Advocacy and Emerging Roles in Cancer Care Payer and Provider Innovative Value-Based Agreement AI and ML Decision Support Models Drug/Biologic Development: To Market; To Out-License; To Be Acquired
  3:00pm - 3:45pm	Disruption or Progress? The 5 Top Things We Must Address to Improve the Future of Cancer Care

*Agenda subject to change.

2021 Summit Faculty

• A – D
• E – H
• I – L
• M – P
• Q – T
• U – Z

• • Murray Aitken, MBA
  • Executive Director
  • IQVIA Institute for Human Data Science

  • Cheryl Allen, PharmD
  • Executive VP
  • Industry Relations & Business Development
  • Asembia

  • Deanna Angello
  • Senior Director
  • Oncology Franchise Strategy & Key Accounts
  • Janssen Oncology

  • Peter Bach, MD, MPP
  • Director
  • Center for Health Policy and Outcomes
  • Memorial Sloan Kettering Cancer Center

  • Robert Baird, RN, MSA
  • President
  • National Cancer Treatment Alliance

  • Ray Bailey, BSPharm, RPh
  • Pharmacy Director
  • Florida Cancer Specialists

  • Carla Balch, AA, BPS, MS
  • CEO & Founder
  • Spesana

  • Jane Barlow, MD, MPH, MBA
  • Chief Clinical Officer
  • Real Endpoints

  • Ankita Batla, MBA, MBBS
  • Chief Medical Officer Lead
  • Health Insights and Patient Partnerships
  • VMLY&Rx

  • Al Benson, MD
  • Professor of Medicine
  • Lurie Cancer Center Northwestern University
  • Past Chair
  • NCCN

  • Jeff Berkowitz, JD
  • CEO
  • Real Endpoints

  • Barbara Bierer, MD
  • Faculty Director
  • Multi-Regional Clinical Trials Center
  • Brigham and Women's Hospital and Harvard

  • David Billiter
  • CEO
  • Deep Lens

  • Sibel Blau, MD
  • President & CEO
  • Quality Cancer Care Alliance Network
  • Medical Director
  • Northwest Medical Specialties

  • Mara Bloom, JD, MS
  • VP
  • Massachusetts General Hospital

  • Jeffrey Bockman, PhD
  • Executive VP
  • Oncology Practice Head
  • Cello Health BioConsulting

  • Brian Bourbeau
  • Associate Director
  • Business Metrics and Analysis
  • ASCO

  • Joel Brill, MD, FACP, AGAF, FASGE, FACG
  • Chief Medical Officer
  • Predictive Health

  • Lili Brillstein, MPH
  • CEO
  • BCollaborative

  • Oren Cahlon, MD
  • Deputy Physician-in-Chief
  • Strategic Partnerships
  • Vice Chair
  • Department of Radiation Oncology

  • Robert Carlson, MD
  • CEO
  • National Comprehensive Cancer Network

  • Arpit Chhabra, MD
  • Director
  • Education & Radiation Oncologist
  • New York Proton Center

  • Nancy Corbitt, BSN, RN, OCN, CRNI
  • Oncology Nurse Navigator
  • University of Maryland Greenebaum Comprehensive Cancer Center

  • John Cox, DO, MBA, FASCO, FACP
  • Medical Director
  • Oncology Services
  • Parkland Hospital

  • Louis Culot, MLA
  • General Manager
  • Genomics and Oncology Informatics
  • Phillips

  • Monica Dean, HON-OPN-CG
  • Director
  • Patient Navigation Program Development
  • The Academy of Oncology Nurse and Patient Navigators

  • Erin Denholm, RN, MSN, RWJENF
  • President
  • Clinical Operations
  • DispatchHealth

  • Joe DePinto
  • Chief Commercial Officer
  • Vineti

  • Michael Diaz, MD
  • Assistant Managing Physician & VP
  • Florida Cancer Specialists

  • Ron DiGiaimo, MBA, FACHE
  • Chairman of the Board
  • Revenue Cycle Coding, RCBIlling, The Oncology Group

  • Melissa Dillmon, MD, FASCO
  • Hematologist/Oncologist
  • Harbin Clinical Medical Oncology Rome

  • Rafael Dodo
  • Manager
  • Upstream Partners

  • Christian Downs, MHA, JD
  • Executive Director
  • Association of Community Cancer Centers

  • Jesse Dresser, Esq.
  • Partner
  • Frier Levitt, LLC

  • Dan Duran
  • SVP & GM
  • Provider Solutions
  • Cardinal Health Specialty Solutions

  • Andrea Dwyer, BS
  • Program Director
  • Colorado Cancer Screening Program
• • Sarah Emond, MPP
  • Executive VP
  • Chief Operating Officer
  • ICER

  • Randy Falkenrath, MBA
  • President
  • Specialty Solutions
  • Onco360

  • Jonathan Fassberg
  • Vice Chairman
  • Healthcare Investment Banking
  • Oppenheimer & Co, Inc.

  • Bruce Feinberg, DO
  • VP
  • Chief Medical Officer
  • Cardinal Health Specialty Solutions

  • Nick Ferreyros
  • Director
  • Communications
  • Community Oncology Alliance

  • Lyn Fitzgerald
  • VP
  • Oncology Sales
  • Ontada

  • Lee Fleisher, MD
  • Chief Medical Officer
  • Centers for Medicare and Medicaid Services

  • Scott Freeswick, MS, PharmD
  • VP
  • CPO
  • Memorial Sloan Kettering Cancer Center

  • Richard Ford, MBA, FMLI, SICS
  • VP
  • Market Access
  • TrialCard

  • John Fox, MD
  • Medical Director
  • Managed Care
  • OneOncology
  • Former Associate Chief Medical Officer

  • Kelly Franchetti, RN, CCRN, CEN
  • Senior VP
  • Global Head Patient Insights & Strategy
  • YPrime

  • Elizabeth Franklin, MSW, PhD
  • President
  • Cancer Support Community

  • John Frownfelter, MD
  • CMIO
  • Jvion

  • Nash Gabrail, MD
  • President
  • Gabrail Cancer Center

  • Ajeet Gajra, MD, MBBS, FACP
  • Chief Medical Officer
  • Cardinal Health Specialty Solutions

  • Bo Gamble
  • Director
  • Strategic Practice Initiatives
  • Community Oncology Alliance

  • Marianne Gandee
  • Senior Director
  • Team Lead
  • Advocacy and Professional Relations
  • Pfizer Oncology

  • Robyn Gartrell, MD, MS
  • Assistant Professor
  • Pediatrics
  • Division of Pediatric Hematology/Oncology
  • Columbia University Irving Medical Center

  • Emily Gentry, BSN, RN, HOH-ONN-CG, OCN
  • Senior Director
  • Education and Program Development
  • The Academy of Oncology Nurse and Patient Navigators

  • Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
  • Program Director
  • Academy of Oncology Nurse & Patient Navigators

  • Rose Gerber
  • Director of Patient Advocacy & Education
  • Patient Advocacy Network
  • Community Oncology Alliance

  • Tammy Glover, RN, MSN, CRNI, OCN
  • Nurse Manager PHIT
  • PA at Penn at Home

  • Brian Gockerman
  • Managing Director
  • Unlimited Systems

  • Bob Gold
  • Chief Behavioral Technologist
  • CEO
  • GoMo Health

  • Patricia Goldsmith
  • CEO
  • CancerCare

  • Lucio Gordan, MD
  • President
  • Florida Cancer Specialists

  • Scott Gottlieb, MD
  • Former Commissioner
  • FDA

  • Stephen Grubbs, MD, FASCO
  • VP
  • Clinical Affairs
  • American Society of Clinical Oncology

  • Christine Hall
  • VP
  • Revenue Cycle
  • American Oncology Network, LLC

  • James Hamrick, MD, MPH
  • Senior Medical Director
  • Clinical Oncology
  • Flatiron Health

  • Tara Henderson, MD, MPH
  • Professor of Pediatrics
  • Director of Cancer Survivorship
  • Co-Leader, Cancer Prevention and Control
  • University of Chicago

  • John Hennessy, MBA
  • Senior VP
  • Strategist
  • Valuate Health Consultancy

  • Mark Hiatt, MD
  • VP
  • Guardant Health

  • Jamie Holloway, PhD
  • Senior Director
  • Molecular Science Liaison
  • Caris Life Science

  • Clifford Hudis, MD
  • CEO
  • American Society of Clinical Oncology
• • Ann Mond Johnson
  • CEO
  • American Telehealth Association [ATA]

  • Kjel Johnson, PharmD
  • VP
  • Specialty Strategy and Client Solutions
  • CVS Health

  • Jordan Johnson, MSHA, iMPaCT
  • Chief Innovation Officer
  • Oncospark

  • Atheer Kaddis, PharmD
  • VP
  • Pharmacy Services
  • Blue Cross Blue Shield of Michigan

  • Mostafa Kamal
  • CEO
  • Magellan Rx Management

  • Deborah Kamin, RN, PhD
  • VP
  • Policy & Advocacy
  • American Society of Clinical Oncology

  • Vivek Kavadi, MD, FASTRO
  • Chief Radiation Oncologist
  • The US Oncology Network

  • Arif Khan
  • VP
  • Pharmacy Services
  • Blue Cross Blue Shield of North Carolina

  • Jonathan Kish, PhD, MPH
  • Senior Director
  • Real World Data & Real World Evidence
  • Cardinal Health Specialty Solutions

  • Ira Klein, MD, MBA, FACP
  • VP
  • Payor Relations
  • Tempus

  • Michael Kolodziej, MD
  • Senior Advisor
  • ADVI Health

  • Scott Kornhauser
  • CEO
  • KlearTrust

  • Tim Kubal, MBA, MD
  • Senior Medical Director
  • Moffitt Cancer Center

  • Cheryl Larson
  • President
  • CEO
  • Midwest Business Group on Health [MBGH]

  • Al Lawson, PhD
  • VP
  • Radiation Oncology Services
  • Tennessee Oncology

  • Harlan Levine, MD
  • President
  • Strategy and Business Ventures
  • City of Hope

  • Jonathan Levitt, Esq.
  • Co-Founding Partner
  • Frier Levitt, LLC

  • Lewis Levy, MD, FACP
  • Chief Medical Officer
  • Teladoc Health, Inc.

  • Doug Long
  • VP
  • Industry Relations
  • IQVIA

  • Roger Longman
  • Founder
  • Chairman
  • Real Endpoints

  • Join Luh, MD, FACP
  • Radiation Oncologist
  • Providence Health
• • Ross Maclean, MD
  • EVP
  • Head of Medical Affairs
  • Precision Value & Health

  • Ameet Malik, MS, MBA
  • CEO
  • Member of the Board of Directors
  • Rafael Holdings, LLC

  • Christopher Marcum, PharmD
  • VP
  • Enterprise Pharmacy
  • Cancer Treatment Centers of America

  • Maurie Markman, MD
  • President
  • Medicine & Science
  • Cancer Treatment Centers of America

  • Barbara McAneny, MD, MACP, FASCO
  • CEO
  • New Mexico Oncology Hematology Consultants

  • Sean McBride, MD, MPH
  • Radiation Oncologist
  • Memorial Sloan Kettering Cancer Center

  • Stacey McCullough, PharmD,
  • Senior VP
  • Tennessee Oncology, LLC

  • William McGivney, PhD
  • Managing Principal
  • McGivney Global Advisors

  • Sean McGowan
  • Senior Director
  • Biosimilars
  • AmerisourceBergen

  • David Memel, MD, MS, MBA
  • VP
  • Specialty Physician Office GPOs
  • Cardinal Health Specialty Solutions

  • Jennifer Mills, MD, PhD, MPH
  • VP, Patient and Professional Partnerships
  • Foundation Medicine

  • Edith Mitchell, MD, MACP, FCPP, FRCP
  • Clinical Professor, Medicine and Medical Oncology
  • Department of Medical Oncology
  • Director
  • Center to Eliminate Cancer Disparities
  • Associate Director, Diversity Affairs
  • Sidney Kimmel Cancer Center at Jefferson
  • 116th President
  • National Medical Association
  • Member
  • President's Cancer Panel

  • Bhavesh Modi, RPh
  • VP
  • Pharmacy
  • Healthfirst

  • Kathi Mooney, PhD, RN, FAAN
  • Louis S. Peery and Janet B. Peery Presidential Endowed Chair in Nursing
  • The University of Utah

  • Heather Morel, PhD
  • SVP & President
  • Provider Solutions
  • McKesson

  • Lee Newcomer, MD
  • Former Senior VP
  • UnitedHealth Group

  • John O'Brien, PharmD, MPH
  • President & CEO
  • National Pharmaceutical Council
  • Former Senior Advisor to Secretary
  • US Department of Health and Human Sciences

  • Rob O'Brien, RPh
  • VP
  • Specialty
  • Real Endpoints

  • Josh Ofman, MD, MSHS
  • Chief Medical Officer
  • External Affairs
  • GRAIL, Inc.

  • Ted Okon, MBA
  • Executive Director
  • Community Oncology Alliance

  • Jeff Patton, MD
  • CEO
  • OneOncology
  • Executive Chairman of the Board
  • Tennessee Oncology

  • Blasine Penkowski
  • Chief Strategic Customer Officer
  • Janssen

  • Steve Peskin, MD, MBA, FACP
  • Executive Medical Director
  • Population Health and Transformation
  • Horizon Blue Cross Blue Shield

  • Jacob Philip
  • Founder
  • MedLever

  • Annette Powers, PharmD, MBA
  • VP
  • Bristol Myers Squibb

  • Bruce Pyenson, FSA, MAAA
  • Principal
  • Milliman
• • Ammar Qadan
  • VP & Global Head
  • Illumina

  • Brian Ragan, PharmD, BCPS
  • Director
  • Value-Based Contracting
  • Humana

  • Susan Raiola
  • President

  • Chevon Rariy, MD
  • National Director
  • Cancer Treatment Centers of America

  • Michael Reff, RPh, MBA
  • Founder & Executive Director

  • Kent Rogers, MBA
  • Chief Customer Officer
  • Former SVP Industry Relations
  • OptumRx

  • Magda Rusinowski
  • VP

  • Barry Russo
  • CEO

  • Sam Salman
  • Chairman
  • miR Scientific, LLC

  • Erin Satterwhite
  • Founder
  • Optum Frontier

  • Charles Saunders, MD
  • CEO
  • Integra Connect

  • Patrick Schmidt
  • CEO
  • FFF Enterprises

  • Lee Schwartzberg, MD
  • Chief Medical Officer
  • OneOncology

  • Jeffrey Scott, MD
  • President
  • Chief Medical Officer
  • Integra Connect

  • Bhavesh Shah, RPh, BCOP
  • Director
  • Specialty Hematology/Oncology Pharmacy
  • Boston Medical Center

  • Nirav Shah, MBA
  • VP
  • Revenue Cycle Management
  • Flatiron Health

  • Iuliana Shapira, MD
  • Chief Medical Officer
  • Regional Cancer Care Associates

  • Jennifer Sherak
  • SVP & President
  • Specialty Physician Services
  • AmerisourceBergen

  • Michael Sherman, MD, MBA
  • Executive VP
  • Chief Medical Officer
  • Point32Health

  • Gregory Simon, JD
  • Former President
  • Biden Cancer Initiative

  • Matthew Skelton, MD
  • Physician
  • The US Oncology Network

  • Jayson Slotnik, JD, MPH
  • Managing Partner
  • Health Policy Strategies

  • Megan Solinger, MHS, MA, OPN-CG
  • Director
  • Service & Care Delivery
  • Ulman Foundation

  • Neeraj Sood, PhD
  • Vice Dean
  • Faculty Affairs and Research
  • USC Sol Price School of Public Policy

  • Tyrone Squires, MBA, CPBS
  • Managing Director
  • TransparentRx

  • James Startare, MBA
  • VP, Benefits
  • Aramark

  • Charles Stevens, JD, MBA
  • Chief Operating Officer
  • COPILOT

  • Lara Strawbridge, MPH
  • Director
  • Division of Ambulatory Payment Models
  • Center for Medicare and Medicaid Innovation

  • Connie Sullivan, BSPharm
  • President
  • CEO
  • National Home Infusion Association

  • Art Taft, MBA, MEng
  • Managing Director
  • Medworks Consulting, LLC

  • Tolga Tanguler, MBA
  • Chief Commercial Officer
  • Alnylam Pharmaceuticals
• • Michael Valenta
  • AVP
  • Oncology Organized Customer, Access & Reimbursement
  • Merck

  • Amy Valley, PharmD
  • VP
  • Clinical Strategy and Technology Solutions
  • Cardinal Health Specialty Solutions

  • Seema Verma, MPH
  • Former Administrator
  • Centers for Medicaid and Medicare Services

  • Nathan Walcker, MBA
  • CEO
  • Florida Cancer Specialists

  • Lalan Wilfong, MD
  • VP
  • Payer Relations and Practice Transformation
  • McKesson

  • Linde Wilson, MBA
  • Managing Partner
  • Upstream Partners
  • Founder
  • Alliance for Innovation in Integrated Healthcare

  • Burt Zweigenhaft, PhD, DLitt.
  • Co-Founder
  • Association for Value-Based Cancer Care

2022 AVBCC Summit FAQs